Hivlife Info, profile picture
Uploaded byHivlife Info
PPTX, PDF908 views

Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle

Embed presentation

Download to read offline
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle
Lo J et al. Statin therapy reduces coronary noncalcified plaque volume in HIV patients a randomized controlled trial. CROI 2015,Seattle

More Related Content

PPTX
Role of statins in secondary prevention in cabg
byPlease hit like if you really liked my PPTs
 
PPTX
CARDIOVASCULAR DISEASE AND DIABETES
byVishwanath Hesarur
 
PPT
HIV and Cardiovascular Disease.How Worried Should We Be ? 2015
byHivlife Info
 
PPT
Determination of prognosis
byGagan Sartaj Singh Sandhu
 
PPTX
Prevention of periodontal disease
byZainab Al Fatlawi
 
PPT
Dental plaque
byParth Thakkar
 
ODP
11diagnosis and treatment_of_periodontal_disease dissan
byiyumva aimable
 
PPTX
Periodontal Disease and its Prevention
byNajeebullah2016
 
Role of statins in secondary prevention in cabg
byPlease hit like if you really liked my PPTs
 
CARDIOVASCULAR DISEASE AND DIABETES
byVishwanath Hesarur
 
HIV and Cardiovascular Disease.How Worried Should We Be ? 2015
byHivlife Info
 
Determination of prognosis
byGagan Sartaj Singh Sandhu
 
Prevention of periodontal disease
byZainab Al Fatlawi
 
Dental plaque
byParth Thakkar
 
11diagnosis and treatment_of_periodontal_disease dissan
byiyumva aimable
 
Periodontal Disease and its Prevention
byNajeebullah2016
 

More from Hivlife Info

PDF
Современный взгляд на АГ и ХСН. Спорные и нерешенные вопросы. Новые возможнос...
byHivlife Info
 
PPT
Cardiovascular Disease in HIV-Infected Patients.Predict It and Prevent It.2015
byHivlife Info
 
PPTX
Longenecker CT et al. (McComsey G presenting) Rosuvastatin arrests progressio...
byHivlife Info
 
PPTX
Grinspoon S.Сердечно-сосудистые заболевания у пациентов с ВИЧ- парадигма и пр...
byHivlife Info
 
PDF
Химиопрофилактика туберкулеза у ВИЧ-позитивных пациентов.СпбНИИФ 2012
byHivlife Info
 
PDF
Эпидемиологическая ситуации по ВИЧ-инфекции в России. 2015.Покровский В.В. Фе...
byHivlife Info
 
PDF
Рекомендации EASL по лечению гепатита С. Краткая версия.2015. RUS
byHivlife Info
 
PDF
С.Н.Кижло.Нежелательные явления на фоне противовирусной терапии ХВГС и способ...
byHivlife Info
 
PDF
“Тяжелые” категории пациентов с хроническим гепатитом C- возможности терапии....
byHivlife Info
 
PPT
EASL 2015. HCV Investigational Agents
byHivlife Info
 
PDF
Факторы риска развития дисплазии и рака шейки матки у ВИЧ-инфицированных жен...
byHivlife Info
 
PPT
Clinical Impact of Data From the CROI 2015,Seattle
byHivlife Info
 
PPT
ART Update 2015
byHivlife Info
 
PPT
Fall 2014 HIV Update.Clinical Impact of New Data From ICAAC 2014, IDWeek 2014...
byHivlife Info
 
PPT
HCV Alerts- Rapid Response to Practice-Changing Advances From EASL 2015
byHivlife Info
 
PPT
The Role of New HCV Agents in Managing HIV/HCV Coinfection.2014
byHivlife Info
 
PPT
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
byHivlife Info
 
PDF
Достижения, несбывшиеся надежды и парадоксы профилактической кардиологии. Р....
byHivlife Info
 
PPT
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
byHivlife Info
 
PPT
Лечение зависимости от табакокурения. [Всё необходимое,чтобы бросить курить.]
byHivlife Info
 
Современный взгляд на АГ и ХСН. Спорные и нерешенные вопросы. Новые возможнос...
byHivlife Info
 
Cardiovascular Disease in HIV-Infected Patients.Predict It and Prevent It.2015
byHivlife Info
 
Longenecker CT et al. (McComsey G presenting) Rosuvastatin arrests progressio...
byHivlife Info
 
Grinspoon S.Сердечно-сосудистые заболевания у пациентов с ВИЧ- парадигма и пр...
byHivlife Info
 
Химиопрофилактика туберкулеза у ВИЧ-позитивных пациентов.СпбНИИФ 2012
byHivlife Info
 
Эпидемиологическая ситуации по ВИЧ-инфекции в России. 2015.Покровский В.В. Фе...
byHivlife Info
 
Рекомендации EASL по лечению гепатита С. Краткая версия.2015. RUS
byHivlife Info
 
С.Н.Кижло.Нежелательные явления на фоне противовирусной терапии ХВГС и способ...
byHivlife Info
 
“Тяжелые” категории пациентов с хроническим гепатитом C- возможности терапии....
byHivlife Info
 
EASL 2015. HCV Investigational Agents
byHivlife Info
 
Факторы риска развития дисплазии и рака шейки матки у ВИЧ-инфицированных жен...
byHivlife Info
 
Clinical Impact of Data From the CROI 2015,Seattle
byHivlife Info
 
ART Update 2015
byHivlife Info
 
Fall 2014 HIV Update.Clinical Impact of New Data From ICAAC 2014, IDWeek 2014...
byHivlife Info
 
HCV Alerts- Rapid Response to Practice-Changing Advances From EASL 2015
byHivlife Info
 
The Role of New HCV Agents in Managing HIV/HCV Coinfection.2014
byHivlife Info
 
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
byHivlife Info
 
Достижения, несбывшиеся надежды и парадоксы профилактической кардиологии. Р....
byHivlife Info
 
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
byHivlife Info
 
Лечение зависимости от табакокурения. [Всё необходимое,чтобы бросить курить.]
byHivlife Info
 

Recently uploaded

PPT
Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Man...
byPVI, PeerView Institute for Medical Education
 
PPT
Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other...
byPeerVoice
 
PDF
Malke Heiman - A Medical Assistant
byMalke Heiman
 
PPTX
Swallowing & Swallowing Disorders SLP_1 lecture 4.pptx
byDr Zonera Khalid PT
 
PPTX
Slenderiiz Dual Drops: Slenderiix & Xceler8 Insider Guide
byDualDrops.com
 
PPTX
Organization, Premises, Equipment & Raw Materials The Pillars of Pharmaceutic...
byDr. Smita Kumbhar
 
PPTX
Transport of Oxygen& CO2.pptx by dr ambareesha
byDr K Ambareesha Goud PhD
 
PPTX
Disease, Spectrum of disease, Iceberg phenomenon of disease
byBindu Nepal
 
PDF
RETINAL VEIN OCCLUSION; CRVO & BRVO types, pathophysiology, diagnosis & manag...
bySamikshaRai22
 
PPTX
REVIEW ON DRUG INTERACTIONS, ADR AND DRUG TOXICITY.pptx
byDr. Vaishnavi B R
 
PPTX
MICROSPORIDIAL KERATITIS , CLINICAL FEATURES , TREATMENT
byDr Aarushi Choudhary
 
PDF
Dyes/ Stain Used In Ophthalmology - Clinical uses, Indication & Side effects....
bySamikshaRai22
 
PPTX
Pressure ulcer Internal KPIs results for July,2024.pptx
byprofyasser95
 
PPTX
Drug Distribution Explained | Pharmacokinetics, Barriers, Vd & Redistribution...
byRGUHS
 
PPTX
Chronic Viral Hepatitis HEP B HEP C HEP D
byNAWEEN KUMAR
 
PPTX
Seminar on Ebola virus , سیمینارێکی ئامادەکراو لەسەر Ebola virus
bydanaShalal2
 
PPTX
Imaging of benign focal lesions of the Liver
byDr. Aryan (Anish Dhakal)
 
PPTX
Drying Pharmaceutical Engineering. pptxx
byShraddha Bandgar
 
PPTX
Endotoxin Testing Using LAL: Practical GMP Approach
byshawkyabdo1
 
PPTX
Drug delivery system- Nanotechnology.pptx
byDr. Vaishnavi B R
 
Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Man...
byPVI, PeerView Institute for Medical Education
 
Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other...
byPeerVoice
 
Malke Heiman - A Medical Assistant
byMalke Heiman
 
Swallowing & Swallowing Disorders SLP_1 lecture 4.pptx
byDr Zonera Khalid PT
 
Slenderiiz Dual Drops: Slenderiix & Xceler8 Insider Guide
byDualDrops.com
 
Organization, Premises, Equipment & Raw Materials The Pillars of Pharmaceutic...
byDr. Smita Kumbhar
 
Transport of Oxygen& CO2.pptx by dr ambareesha
byDr K Ambareesha Goud PhD
 
Disease, Spectrum of disease, Iceberg phenomenon of disease
byBindu Nepal
 
RETINAL VEIN OCCLUSION; CRVO & BRVO types, pathophysiology, diagnosis & manag...
bySamikshaRai22
 
REVIEW ON DRUG INTERACTIONS, ADR AND DRUG TOXICITY.pptx
byDr. Vaishnavi B R
 
MICROSPORIDIAL KERATITIS , CLINICAL FEATURES , TREATMENT
byDr Aarushi Choudhary
 
Dyes/ Stain Used In Ophthalmology - Clinical uses, Indication & Side effects....
bySamikshaRai22
 
Pressure ulcer Internal KPIs results for July,2024.pptx
byprofyasser95
 
Drug Distribution Explained | Pharmacokinetics, Barriers, Vd & Redistribution...
byRGUHS
 
Chronic Viral Hepatitis HEP B HEP C HEP D
byNAWEEN KUMAR
 
Seminar on Ebola virus , سیمینارێکی ئامادەکراو لەسەر Ebola virus
bydanaShalal2
 
Imaging of benign focal lesions of the Liver
byDr. Aryan (Anish Dhakal)
 
Drying Pharmaceutical Engineering. pptxx
byShraddha Bandgar
 
Endotoxin Testing Using LAL: Practical GMP Approach
byshawkyabdo1
 
Drug delivery system- Nanotechnology.pptx
byDr. Vaishnavi B R